In crisis or thinking about suicide? Call or text 988 for the Suicide and Crisis Lifeline. Free, confidential, available 24/7.
Missouri Depression HelpPublic Health Guide
From our survey

A Missouri guide for doubters weighing care without drugs

For skeptics across a big state: drug-free options in plain terms, coverage, distance, and how to question every clinic you consider.

Missouri is a big state to be depressed in. From the Bootheel, the Ozarks, or a small town on Highway 36, the nearest psychiatrist can be an hour or more away, and when options feel scarce it is easy to take whatever is offered. If you doubt ketamine therapy and would rather not add another drug, you deserve to know what else exists and how to reach it from where you live.

This guide rests on our commissioned summer survey and on the practical realities of getting care in Missouri. It is not medical advice; it is meant to help you ask sharper questions.

What the survey found

Our 443 respondents, all between 18 and 64, came from Missouri and nine bordering or nearby states, and two findings shape this guide.

First, doubt about ketamine therapy is common. Faced with the idea of ketamine therapy, one group of respondents, 21 percent, started out skeptical and 9 percent felt negative, while cautious openness, the most common, came from 34 percent.

Second, many people want treatment without medication and do not know where to find it. A medication-free path appealed to 64 percent of respondents, yet only 25 percent knew what TMS, the best-known drug-free brain stimulation treatment, is, and half the sample had never heard of TMS but valued a drug-free option.

The survey has no breakdown for doubters, so how they answered about TMS is unknown; all figures are final.

Your drug-free options, plainly

Psychotherapy. Structured therapy with a licensed counselor, social worker, or psychologist. Cognitive behavioral therapy and similar approaches are well established for depression, and telehealth has put them within reach of rural Missourians.

TMS. Transcranial magnetic stimulation stimulates a mood-related region of the brain with a coil on the scalp. You stay awake, there is no anesthesia, and most people drive home. The FDA cleared it for grown-ups with major depression that antidepressants never lifted. The catch is frequency, since a standard course asks for visits nearly every weekday for several weeks.

Ketamine and esketamine are medications and do not belong on this list. Esketamine, sold as Spravato, won its FDA approval in treatment-resistant depression and is administered at certified sites with supervision; Brain Recovery Centers keeps a Spravato treatment page explaining that setting. Infused ketamine is used off label, and home kits are regulated more loosely still. If these leave you doubtful, say so and ask about the options above.

Step one: decide whom to ask

Most respondents would start with their regular doctor. Asked where they would first turn for a new depression treatment, 56 percent picked primary care and 23 percent a psychiatrist or mental health provider, while 5 percent would not know where to begin.

If you have a doctor you trust, start there; for 74 percent of respondents, that doctor's advice would carry the most weight. Without a regular doctor, Missouri's community behavioral health organizations serve every region, take MO HealthNet, and do not turn people away over money, which makes them a front door to therapy and psychiatric evaluation.

Military families can bring the same questions to their own doctor. If TRICARE is part of your coverage, ask whether TMS or evidence-based therapy is covered and what referral comes first.

Step two: learn what your coverage will do

Coverage topped respondents' priorities: 85 percent put insurance in their top two when choosing a provider, and half would take insurance with extra steps over paying out of pocket to start faster.

Our sample's payers were broad. More than one answer was allowed; 39 percent of respondents listed a commercial plan, 37 percent Medicaid, 23 percent Medicare, 5 percent TRICARE, and 9 percent no insurance.

  • Is TMS for depression covered, what comes first, and does the plan want past medication records?
  • How many therapy sessions are covered, and do video sessions count the same?
  • Which nearby providers are in network?

For MO HealthNet members, the number on the health plan card is the quickest route to a real answer.

Step three: be honest about distance

Location mattered too, with 43 percent of respondents ranking a nearby provider in their top two, and across much of Missouri it is the hardest factor to satisfy.

  • Near St. Louis, Kansas City, Springfield, or Columbia, a TMS provider is more likely within a daily drive; ask about early and late slots.
  • In rural areas, a daily TMS schedule may not be practical unless you can stay near a clinic for a while; ask whether an accelerated schedule is possible.
  • Anywhere, therapy by video removes the drive.

Step four: question everything, the clinic included

  • What exactly has the FDA approved or cleared this treatment for?
  • Who evaluates me, and what could rule me out?
  • How will we know it is working?
  • What do I owe if insurance says no?

Be wary of clinics that promise results or push for payment up front. Respondents cared about regulatory standing, with 59 percent saying FDA approval would be decisive or a big factor, and a trustworthy provider will be exact about it.

Step five: do not do it alone

After their own doctor, respondents most trusted a close friend or family member, at 18 percent. A relative who helps with calls, paperwork, or a long drive can make a real difference, especially in rural Missouri.

Whatever you explore, stay on your current prescription until its prescriber helps you plan a change; stopping suddenly can make things worse.

Should suicidal thoughts arrive, 988 answers calls and texts from anywhere in Missouri. It is free and private, and it never closes.

Methodology

Funded and commissioned by our publisher, the fieldwork ran through Pollfish and ended June 23, 2026. Exactly 443 people completed it, all of them consenting adults ages 18 through 64 living in ten Midwest states. Where respondents could pick several answers, shares use everyone as the base and may add past 100. Every figure is final.